Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 406 AL 420

Opportunities and challenges in developing Alzheimer disease therapeutics

Iqbal K, Grundke-Iqbal I.

Acta Neuropathol. 2011 Nov;122(5):543-9. doi: 10.1007/s00401-011-0878-z. Epub 2011 Sep 30.

Dietary lipids and their oxidized products in Alzheimer's disease

Corsinovi L, Biasi F, Poli G, Leonarduzzi G, Isaia G.

Mol Nutr Food Res. 2011 Sep;55 Suppl 2:S161-72. doi: 10.1002/mnfr.201100208. Epub 2011 Aug 31.

Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial

Kamphuis PJ, Verhey FR, Olde Rikkert MG, Twisk JW, Swinkels SH, Scheltens P.

J Nutr Health Aging. 2011 Aug;15(8):672-6. doi: 10.1007/s12603-011-0339-3.

A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor

Weinreb O, Amit T, Bar-Am O, Youdim MB.

Int Rev Neurobiol. 2011;100:191-215. doi: 10.1016/B978-0-12-386467-3.00010-8.

Evaluation and tracking of Alzheimer's disease severity using resting-state magnetoencephalography

Verdoorn TA, McCarten JR, Arciniegas DB, Golden R, Moldauer L, Georgopoulos A, Lewis S, Cassano M, Hemmy L, Orr W, Rojas DC.

J Alzheimers Dis. 2011;26 Suppl 3:239-55. doi: 10.3233/JAD-2011-0056.

APP transgenic mice and their application to drug discovery

Howlett DR.

Histol Histopathol. 2011 Dec;26(12):1611-32. doi: 10.14670/HH-26.1611.

Clinical research on comprehensive treatment of senile vascular dementia

Chen LP, Wang FW, Zuo F, Jia JJ, Jiao WG.

J Tradit Chin Med. 2011 Sep;31(3):178-81. doi: 10.1016/s0254-6272(11)60036-8.

Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease

Gahete MD, Córdoba-Chacón J, Kineman RD, Luque RM, Castaño JP.

Peptides. 2011 Nov;32(11):2225-8. doi: 10.1016/j.peptides.2011.09.019. Epub 2011 Oct 1.

Current and emerging drug treatment options for Alzheimer's disease: a systematic review

Herrmann N, Chau SA, Kircanski I, Lanctôt KL.

Drugs. 2011 Oct 22;71(15):2031-65. doi: 10.2165/11595870-000000000-00000.

Comparison between Alzheimer's disease and subcortical vascular dementia: attentional cortex study in functional magnetic resonance imaging

Li C, Zheng J, Wang J, Gui L.

J Int Med Res. 2011;39(4):1413-9. doi: 10.1177/147323001103900428.

Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly

Sardi F, Fassina L, Venturini L, Inguscio M, Guerriero F, Rolfo E, Ricevuti G.

Autoimmun Rev. 2011 Dec;11(2):149-53. doi: 10.1016/j.autrev.2011.09.005. Epub 2011 Oct 5.

Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial

Annweiler C, Fantino B, Parot-Schinkel E, Thiery S, Gautier J, Beauchet O.

Trials. 2011 Oct 20;12:230. doi: 10.1186/1745-6215-12-230.

The corticobasal syndrome-Alzheimer's disease conundrum

Hassan A, Whitwell JL, Josephs KA.

Expert Rev Neurother. 2011 Nov;11(11):1569-78. doi: 10.1586/ern.11.153.

Treatment of Alzheimer disease: the past, the present, and the future

Gauthier S.

Can J Psychiatry. 2011 Oct;56(10):577-8. doi: 10.1177/070674371105601001.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias